Abstract
Compound 20 (CVT-3146--a 2-[(N-1-(4-N-methylcarboxamidopyrazolyl)] adenosine derivative) and compound 31 (CVT-3033--a 2-[(4-(1-N-pentylpyrazolyl)] adenosine derivative), were found to be short acting functionally selective coronary vasodilators (CV t0.5 = 5.2 +/- 0.2 and 3.4 +/- 0.5 min, respectively--rat isolated heart 50% reversal time) with good potency (EC50S = 6.4 +/- 1.2 nM and 67.9 +/- 16.7 nM, respectively), but they possess low affinity for the ADO A2A receptor (Ki = 1122 +/- 323 nM and 2138 +/- 952 nM, respectively; pig striatum).
MeSH terms
-
Adenosine / analogs & derivatives*
-
Adenosine / chemistry
-
Adenosine / pharmacology
-
Animals
-
Brain / metabolism
-
Coronary Vessels / drug effects*
-
Humans
-
In Vitro Techniques
-
Kinetics
-
Models, Molecular
-
Purinergic P1 Receptor Agonists*
-
Rats
-
Receptor, Adenosine A2A
-
Receptors, Purinergic P1 / metabolism
-
Structure-Activity Relationship
-
Swine
-
Vasodilator Agents / chemistry
-
Vasodilator Agents / metabolism
-
Vasodilator Agents / pharmacology*
Substances
-
Purinergic P1 Receptor Agonists
-
Receptor, Adenosine A2A
-
Receptors, Purinergic P1
-
Vasodilator Agents
-
Adenosine